Cirrhosis causes portal hypertension by physically obstructing blood flow through the liver and triggering chemical changes that make the problem worse over time. The portal vein normally carries nutrient-rich blood from your digestive organs through the liver at low pressure. When cirrhosis replaces healthy liver tissue with scar tissue and clusters of regenerating cells, that blood can no longer pass through easily. Pressure in the portal system rises, and the body responds in ways that, paradoxically, drive the pressure even higher.
How Scar Tissue Blocks Normal Blood Flow
A healthy liver has a sponge-like network of tiny blood vessels called sinusoids. Blood flows through these channels slowly, giving liver cells time to filter toxins, process nutrients, and produce proteins. In cirrhosis, dense bands of fibrous scar tissue surround clusters of regenerating liver cells, forming what are called regenerative nodules. These nodules physically compress the small veins that drain blood out of the liver, creating a bottleneck.
The body tries to work around this obstruction. New small blood vessels grow within the fibrous tissue, reconnecting branches of the portal vein to outflow veins. But these bypass vessels are narrow and operate under higher pressure than normal sinusoids. They simply cannot handle the same volume of blood. The result is a backup of pressure into the portal vein, much like a highway narrowing from four lanes to one creates a traffic jam that extends miles behind the bottleneck.
Stiffening of the Sinusoid Walls
Beyond the physical compression from scar tissue, the sinusoids themselves change in a process called capillarization. Normally, sinusoid walls are full of tiny pores that allow fluid and molecules to pass freely between the blood and liver cells. In cirrhosis, cells lining the sinusoids begin depositing a type of structural protein (collagen) that forms a continuous basement membrane where one didn’t exist before. This membrane seals those pores and stiffens the vessel walls.
Research published in JCI Insight showed that this basement membrane does double damage. It directly increases the rigidity of sinusoid walls, raising resistance to blood flow. It also acts as a scaffold for additional scar proteins to accumulate, making the vessels even stiffer over time. This progressive stiffening means portal pressure doesn’t just rise once and stabilize. It tends to climb as the disease advances.
Active Contraction Inside the Liver
Scar tissue and stiff sinusoids create what’s called the “fixed” component of portal hypertension, the part that doesn’t change from moment to moment. But there’s also a “dynamic” component driven by cells that actively squeeze the remaining blood vessels.
Scattered throughout the liver are stellate cells. In a healthy liver, these cells are quiet, mainly storing vitamin A. When the liver is injured, stellate cells transform into a muscle-like state and gain the ability to contract. They wrap around sinusoids and tighten them the way a fist squeezes a garden hose. Calcium flooding into these activated cells triggers the contraction, and studies have confirmed that the degree of contraction directly correlates with how much calcium enters the cell.
At the same time, the cirrhotic liver produces less nitric oxide, the molecule that normally tells blood vessels to relax and widen. It also produces more of a powerful local vasoconstrictor called endothelin-1. This imbalance, too much constriction and not enough relaxation inside the liver, layers additional resistance on top of the structural damage. Some estimates suggest this dynamic component accounts for 20 to 30 percent of the total resistance in portal hypertension.
Why Blood Inflow Keeps Increasing
If high resistance inside the liver were the whole story, portal pressure might eventually plateau. Instead, the body makes things worse through a compensatory response in the digestive organs. As pressure builds in the portal system, blood vessels supplying the stomach, intestines, and spleen begin to widen. This splanchnic vasodilation increases the volume of blood flowing into the portal vein, pushing pressure higher even as the liver’s ability to accept that blood remains compromised.
This creates a vicious cycle. Rising portal pressure triggers more vasodilation in the gut, which sends more blood into the portal system, which raises pressure further. It’s a feedback loop that explains why portal hypertension tends to worsen progressively rather than reaching a steady state.
Collateral Vessels and Varices
Faced with a high-pressure roadblock at the liver, blood finds alternative routes back to the heart. New pathways, called portosystemic collaterals, open up through veins that normally carry only small amounts of blood. These collaterals develop in predictable locations:
- Esophagus and stomach: Veins along the lower esophagus and upper stomach swell into varices, thin-walled bulges that can rupture and cause life-threatening bleeding.
- Rectum: Rectal veins can enlarge, sometimes mistaken for hemorrhoids.
- Abdominal wall: Veins around the belly button can become visible under the skin.
- Retroperitoneum: Deep veins near the duodenum and colon can form collateral pathways that drain into pelvic veins.
These collateral vessels partially decompress the portal system, but they were never designed to handle this volume of blood. Their walls are fragile, and the pressure they carry is still abnormally high. Gastroesophageal varices are the most clinically dangerous because they sit in areas prone to mechanical irritation from food and stomach acid.
Consequences Beyond the Veins
Portal hypertension doesn’t just affect blood vessels. The elevated pressure drives fluid out of blood vessels in the abdominal cavity, contributing to ascites, the buildup of fluid in the belly. This happens through a combination of forces: high pressure inside portal vessels pushes fluid outward, while low levels of albumin (a protein the damaged liver can no longer produce adequately) reduce the blood’s ability to hold onto that fluid. The kidneys compound the problem by aggressively retaining sodium and water, expanding blood volume further.
The spleen also suffers. Because the splenic vein feeds directly into the portal vein, rising portal pressure backs up into the spleen, causing it to enlarge. An enlarged spleen traps more blood cells, particularly platelets, leading to low platelet counts. However, reduced platelet counts in advanced cirrhosis are also driven by the liver’s declining production of thrombopoietin, the hormone that signals the bone marrow to make platelets. The low platelet count itself becomes a useful clinical marker: a platelet count below 150,000 per microliter, combined with liver stiffness measurements, helps doctors estimate whether portal hypertension has reached a clinically significant level.
How Portal Pressure Is Monitored
Clinically significant portal hypertension is defined as a pressure gradient of 10 mmHg or more between the portal vein and the hepatic veins. Measuring this directly requires threading a catheter into the liver’s veins, which isn’t practical for routine monitoring. Instead, current guidelines endorsed through the Baveno VII consensus allow doctors to estimate portal pressure noninvasively using two simple measurements: liver stiffness (assessed by a quick ultrasound-based scan) and platelet count from a standard blood test.
A liver stiffness reading of 25 kPa or higher correctly identifies clinically significant portal hypertension about 92 percent of the time. On the other end, a stiffness below 15 kPa combined with a platelet count above 150,000 per microliter rules it out with 99 percent accuracy. These thresholds let doctors track the progression of portal hypertension without invasive procedures, guiding decisions about screening for varices and starting preventive treatment.